| Age, yrs |
56.7 ± 11.1 |
55.3 ± 11.9 |
59.7 ± 8.88 |
0.042 |
| Female |
58 (42.3%) |
35 (37.6%) |
23 (52.3%) |
0.152 |
| History of atrial fibrillation, months |
71.0 (36.0−108)*
|
66.0 (32.0−100)*
|
87.5 (44.3−116)*
|
0.073 |
| Previous transient ischemic attack/stroke |
16 (11.7%) |
11 (11.8%) |
5 (11.4%) |
1.000 |
| Coronary heart diseases |
17 (12.4%) |
8 (8.6%) |
9 (20.5%) |
0.091 |
| Chronic congestive heart failure |
3 (2.2%) |
2 (2.2%) |
1 (2.3%) |
1.000 |
| Peripheral vascular diseases |
32 (23.4%) |
18 (19.4%) |
14 (31.8%) |
0.163 |
| Smoking status |
39 (28.5%) |
24 (25.8%) |
15 (34.1%) |
0.423 |
| Drinking status |
19 (13.9%) |
15 (16.1%) |
4 (9.1%) |
0.396 |
| Fasting blood glucose, mmol/L |
5.54 ± 3.84 |
5.51 ± 4.51 |
5.62 ± 1.77 |
0.026 |
| Triglycerides, mmol/L |
1.80 ± 1.31 |
1.38 ± 0.53 |
2.70 ± 1.91 |
< 0.001 |
| High-density lipoprotein cholesterol, mmol/L |
1.11 ± 0.30 |
1.19 ± 0.29 |
0.94 ± 0.24 |
< 0.001 |
| Body mass index, kg/m2
|
24.9 ± 3.19 |
24.1 ± 2.87 |
26.6 ± 3.16 |
< 0.001 |
| Overweight/obesity |
67 (48.9%) |
30 (32.3%) |
37 (84.1%) |
< 0.001 |
| High blood pressure |
60 (43.8%) |
23 (24.7%) |
37 (84.1%) |
< 0.001 |
| High blood glucose |
33 (24.1%) |
12 (12.9%) |
21 (47.7%) |
< 0.001 |
| Hypertriglyceridemia |
54 (39.4%) |
20 (21.5%) |
34 (77.3%) |
< 0.001 |
| Low high-density lipoprotein cholesterol |
42 (30.7%) |
14 (15.1%) |
28 (63.6%) |
< 0.001 |
| Left atrium diameter, mm |
36.1 ± 6.34 |
34.8 ± 5.50 |
38.8 ± 7.17 |
< 0.001 |
| Left ventricular end-diastolic diameter, mm |
47.8 ± 4.82 |
47.4 ± 4.70 |
48.5 ± 5.02 |
0.235 |
| Left ventricular ejection fraction, % |
65.8 ± 5.19 |
65.7 ± 4.89 |
66.2 ± 5.83 |
0.597 |
| CHA2DS2-VASc score
|
1.8 ± 1.47 |
1.4 ± 1.37 |
2.6 ± 1.37 |
< 0.001 |
| HAS-BLED score |
1.2 ± 0.98 |
1.0 ± 1.01 |
1.6 ± 0.82 |
0.001 |
